Status:

WITHDRAWN

Regulation of the Release of Inflammatory Mediators From Blood Leukocytes

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

Asthma UK

Conditions:

Chronic Obstructive Airway Disease

Healthy Volunteers

Eligibility:

All Genders

21-75 years

Brief Summary

Chronic obstructive pulmonary disease (COPD for short) involves inflammation inside the air passages of the lungs. This inflammation might be partly responsible for the shortness of breath, cough and ...

Detailed Description

The aim of this study is to investigate the mechanisms that regulate the survival of blood leukocytes as well as the synthesis and release of inflammatory mediators from cells from normal individuals ...

Eligibility Criteria

Inclusion

  • Healthy non-smoking subjects: All normal volunteers will meet the following criteria:
  • Age 21-70 years.
  • No history of respiratory or allergic disease.
  • Normal baseline spirometry as predicted for age, sex and height.
  • Non-smokers.
  • No history of upper respiratory tract infection in the preceding six weeks.
  • Not taking regular medication
  • COPD subjects: COPD is diagnosed according to American Thoracic Society, European Respiratory Society and British Thoracic Society guidelines by the doctors in Professor Barnes' COPD clinic. All COPD volunteers will meet the following criteria:
  • Age between 40-75 years.
  • A smoking history of at least 20 pack years. ( 1 pack year = 20 cigarettes per day for 1 year)
  • FEV1:FVC ratio of \<0.7, post-bronchodilator FEV1 of \<85% predicted, reversibility with inhaled b2-agonist of \<15% of predicted FEV1: all three criteria are required.
  • Current smokers or smokers who had ceased smoking for at least 6 months.
  • No history of exacerbation, oral steroid or antibiotic use within the preceding 6 weeks.
  • Normal serum a-1 antitrypsin level.
  • No history of other respiratory or allergic disease.
  • No evidence of atopy on skin prick testing to common aeroallergens (grass pollen, cat hair, house dust mite or Aspergillus fumigatus
  • These tests will have already been performed as part of routine assessment in Professor Barnes' COPD clinic and we will not need to repeat them for this study.
  • Healthy Smokers: All healthy smoking volunteers in trials will meet the following criteria:
  • Age 21-70 years.
  • Smoking history of at least 10 pack years (1 pack year = 20 cigarettes per day for 1 year).
  • No history of respiratory or allergic disease.
  • Normal baseline spirometry as predicted for age, sex and height.
  • No history of upper respiratory tract infection in the preceding six weeks.
  • Not taking regular medication.

Exclusion

  • Subjects will not included in this study if they meet any of the following exclusion criteria:
  • Clinically significant findings in the medical history or on physical examination other than those of COPD in the COPD group.
  • Pregnant women or mothers who are breastfeeding.
  • Subjects who are unable to give informed consent.

Key Trial Info

Start Date :

October 1 2001

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00180765

Start Date

October 1 2001

End Date

February 1 2008

Last Update

July 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Heart & Lung Institute, Imperial College

Chelsea, London, United Kingdom, SW3 6LY